Thyroid Disease CARE Act of 2025
The source supplies the latest action, but no lifecycle stage.
Latest action (18 Dec 2025): Referred to the House Committee on Energy and Commerce.
What this bill does
H.R. 6897, the Thyroid Disease CARE Act of 2025, would direct the Secretary of Health and Human Services to advance research, promote awareness, and improve healthcare for thyroid disease. This includes supporting research into the causes, diagnosis, and treatment of thyroid disease, with a focus on thyroid cancer survivorship and disparities in care based on factors like race, ethnicity, and insurance status. The bill also proposes analyzing research gaps and disproportionate impacts on specific populations, particularly women, and developing recommendations for better diagnosis, treatment, and payment options.
The bill aims to affect individuals with thyroid disease, healthcare professionals, and researchers. It would mandate a public awareness campaign to inform the public and healthcare providers about thyroid disease signs, symptoms, and treatment options, with an emphasis on high-risk groups. The legislation also authorizes appropriations for these activities, including $30 million annually for fiscal years 2026-2030 for research and analysis, and $3 million annually for the public awareness campaign.
As of its introduction on December 18, 2025, H.R. 6897 has been referred to the House Committee on Energy and Commerce. If passed by the House, it would then proceed to the Senate for consideration. The bill outlines specific reporting timelines for the Secretary to provide updates on research and analysis findings to Congress and make them publicly available.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Timeline
18 Dec 2025
Referred to the House Committee on Energy and Commerce.
Common questions
- What does H.R. 6897 do?
- H.R. 6897, the Thyroid Disease CARE Act of 2025, would direct the Secretary of Health and Human Services to advance research, promote awareness, and improve healthcare for thyroid disease. This includes supporting research into the causes, diagnosis, and treatment of thyroid disease, with a focus on thyroid cancer survivorship and disparities in care based on factors like race, ethnicity, and insurance status. The bill also proposes analyzing research gaps and disproportionate impacts on specific populations, particularly women, and developing recommendations for better diagnosis, treatment, and payment options. The bill aims to affect individuals with thyroid disease, healthcare professionals, and researchers. It would mandate a public awareness campaign to inform the public and healthcare providers about thyroid disease signs, symptoms, and treatment options, with an emphasis on high-risk groups. The legislation also authorizes appropriations for these activities, including $30 million annually for fiscal years 2026-2030 for research and analysis, and $3 million annually for the public awareness campaign. As of its introduction on December 18, 2025, H.R. 6897 has been referred to the House Committee on Energy and Commerce. If passed by the House, it would then proceed to the Senate for consideration. The bill outlines specific reporting timelines for the Secretary to provide updates on research and analysis findings to Congress and make them publicly available.
- Has H.R. 6897 become law?
- The source does not supply a confirmed lifecycle stage for H.R. 6897. Check the latest action and official source below.
- Who sponsored H.R. 6897?
- H.R. 6897 was sponsored by Rep. Stevens, Haley M. [D-MI-11] (D-MI), with 1 cosponsor.
- What's the latest action on H.R. 6897?
- Referred to the House Committee on Energy and Commerce. (18 Dec 2025).
Related bills in Health
Choices for Increased Mobility Act of 2026
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Access to Medical Supplies Act
Lower Premiums, Faster Payments Act
More bills from Rep. Stevens, Haley M. [D-MI-11]
Data Science and Literacy Act of 2026
Supporting the designation of September 17, 2026, as "National Physician Suicide Awareness Day" to raise awareness of, and promote a national discussion about, physician suicide and to reduce the stigma of mental health conditions, and for other purposes.
Recognizing and supporting the continued efforts and contributions of the City of Ferndale to the LGBTQIA+ community of the State of Michigan.
DOE and NSF Interagency Research Act
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.